2017 American Transplant Congress
Malignancy in Patients Undergoing Simultaneous Heart-Liver and Heart-Kidney Transplant.
University of Pennsylvania, Philadelphia, PA
Purpose: While evidence suggests that patients undergoing simultaneous heart-liver and heart-kidney transplant may have improved immunoprotection from allograft rejection versus patients undergoing heart transplant only,…2017 American Transplant Congress
Titers of Blood Group B Patients Using Non-A1 Reagent/Donor Cells for the Purpose of ABO Incompatible Kidney Transplantation.
NJ Sharing Network, New Providence
Background: Blood group B patients are eligible to receive offers from non-A1 or non-A1B kidney donors. Current practice in many institutions involves performing these titers…2017 American Transplant Congress
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.
Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…2017 American Transplant Congress
Increased Expression of Fibrillin-1 and Presence of Fibroblastic Reticular Cells in Treg-Rich Organized Lymphoid Structures (TOLS) of Accepted Kidney Allografts.
Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA
Background: Fibrillin-1, found in connective tissue, plays a role in the sequestration of TGF-b, and is produced by fibroblastic reticular cells (FRCs). It has been…2017 American Transplant Congress
Direct Comparison of Hypothermic and Normothermic Organ Preservation in a Porcine Ex-Vivo Kidney Model.
Background: Hypothermic machine perfusion is a well established method for deceased donor organ preservation as well as pre-transplant assessment and preconditioning. Recent translational and clinical…2017 American Transplant Congress
Effect of Everolimus-Based Regimen on Graft Outcomes in Kidney Transplant Recipients with Diabetes at Baseline: Post-Hoc Analysis from the ELEVATE Study.
1ELEVATE Study Group, Leiden, Netherlands; 2Novartis Pharma AG, Basel, Switzerland
Purpose: Presence of diabetes may have adverse impact on graft outcome in kidney transplant recipients (KTxRs). This post-hoc analysis from the ELEVATE study compared the…2017 American Transplant Congress
The Efficacy and Safety of Plaquenil in Kidney Transplants Patients with Lupus.
Background: Hydroxychloroquine, also known as Plaquenil ( PLQ) is an antimalarial drug with immunomodulatory action. Recent studies have demonstrated a protective effect of PLQ in…2017 American Transplant Congress
Lipid Abnormalities and Cardiovascular Events After Early Conversion to Everolimus in Kidney Transplant Recipients with Pretransplant Diabetes: 24-Month Analysis from Elevate Study.
1ELEVATE Study Group, Berlin, Germany; 2Novartis Pharma AG, Basel, Switzerland
PURPOSE: Pretransplant (preTx) diabetes is an independent risk factor for cardiovascular (CV) events, and posttransplant (post-Tx) hyperlipidemia further increases CV risk. To analyze the influence…2017 American Transplant Congress
Persistent Hypophosphatemia Among Deceased-Donor Kidney Transplant Recipients Is Donor-Dependent and Associated with Superior Long-Term Allograft Outcomes.
Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany
Significant variations in posttransplant phosphate levels are recognized after kidney transplantation, and associated with more favorable allograft outcomes. Although posttransplant hypophosphatemia may be associated with…2017 American Transplant Congress
Successful Implementation of a Pneumococcal Vaccination Program for Pediatric Kidney Transplant Recipients.
Medical University of South Carolina, Charleston
Vaccine preventable diseases remain a serious problem among transplanted patients. Many children remain under vaccinated after a kidney transplant because of a lack of physician…
- « Previous Page
- 1
- …
- 363
- 364
- 365
- 366
- 367
- …
- 531
- Next Page »